[Piperacillin-tazobactam in the treatment of severe nosocomial infections]
- PMID: 11942173
[Piperacillin-tazobactam in the treatment of severe nosocomial infections]
Abstract
Epidemiology and clinical manifestations of nosocomial infections have been progressively evolving through last three decades. New pathogens, often associated to multiple antibiotic-resistances, are now among the leading etiologies in a patient population mainly represented by individuals debilitated by serious underlying diseases, immunosuppressive treatments and multiple diagnostic and therapeutic invasive procedures. Under these circumstances, when an infectious complication develops, prompt initiation of empiric antibiotic therapy, based on general and/or local epidemiology of nosocomial infections, may be crucial for survival of more critically ill patients. Based on recent data, the antibiotics of choice for treatment of nosocomial infections should have not only a bactericidal activity and a broad antibacterial spectrum, but also poor propensity to induce antibiotic-resistance and a satisfactory pharmacoeconomy profile. After a detailed description of the above mentioned context, the pre-eminent role of piperacillin-tazobactam in the treatment of nosocomial infections is reviewed and discussed.
Similar articles
-
Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison.Support Care Cancer. 2003 Jun;11(6):362-70. doi: 10.1007/s00520-003-0463-7. Epub 2003 Apr 11. Support Care Cancer. 2003. PMID: 12690546 Clinical Trial.
-
Conjugative resistance to tazobactam plus piperacillin among extended-spectrum beta-lactamase-producing nosocomial Klebsiella pneumoniae.Scand J Infect Dis. 2001;33(7):512-5. doi: 10.1080/00365540110026520. Scand J Infect Dis. 2001. PMID: 11515761
-
Piperacillin/tazobactam in the treatment of Klebsiella pneumoniae infections in neonates.Am J Perinatol. 1998 Jan;15(1):47-51. doi: 10.1055/s-2007-993898. Am J Perinatol. 1998. PMID: 9475688
-
Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections.Drugs. 1999 May;57(5):805-43. doi: 10.2165/00003495-199957050-00017. Drugs. 1999. PMID: 10353303 Review.
-
Piperacillin/tazobactam: a pharmacoeconomic review of its use in moderate to severe bacterial infections.Pharmacoeconomics. 2001;19(11):1135-75. doi: 10.2165/00019053-200119110-00006. Pharmacoeconomics. 2001. PMID: 11735679 Review.